MENU
SLNCF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Silence Therapeutics (SLNCF) Ownership - Who owns Silence Therapeutics?

Profile

Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
772.16M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.18 USD as % of share price

Fundamentals

SLNCF
Capitalization
772M
P/E Ratio
N/A
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.18%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
5.40
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
12.82
Current Revenue Per Employee
113816.52
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
82.16
Revenue To Assets
N/A
Shares Held By Institutions
167
Shares Outstanding - Current
140M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
266.667
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com